U.S. Markets open in 8 hrs 22 mins

IXICO plc (IXI.L)

LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
78.500.00 (0.00%)
At close: 3:13PM BST

IXICO plc

Griffin Court
4th Floor 15 Long Lane
London EC1A 9PN
United Kingdom
44 20 3763 7499
http://www.ixico.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees82

Key Executives

NameTitlePayExercisedYear Born
Mr. Giulio CerroniCEO & Director537.66kN/A1962
Mr. Grant NashCFO, Company Sec. & Exec. Director199.44kN/AN/A
Prof. Daniel RueckertCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Prof. Derek Lionel Glendon HillCo-Founder and Pres of Regulatory Science & External RelationsN/AN/A1966
Prof. David HawkesCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Prof. Joseph HajnalCo-Founder & Member of Scientific Advisory BoardN/AN/AN/A
Mr. Marcus ThorntonChief Operating OfficerN/AN/AN/A
Mr. Mark AustinDirector of TechnologyN/AN/AN/A
Ms. Hannah EsfahanianHR Mang.N/AN/AN/A
Dr. John HallSr. VP of Bus. Devel.N/AN/A1979
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

IXICO plc provides data analytics services to the biopharmaceutical industry in the United States, the United Kingdom, Europe, and internationally. It provides collection, analysis, management, and reporting services on data generated in the course of a clinical study. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer. The company offers end-to-end imaging services in the fields of Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, And Progressive Supranuclear Palsy, Spinocerebellar Ataxia, and Friedreich's Ataxia diseases, as well as other movement disorders and dementias; and engages in the data collection and analysis of neurological diseases. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was incorporated in 1995 and is based in London, the United Kingdom.

Corporate Governance

IXICO plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.